Description
THERAPEUTIC APHEREISIS
First action · last action
2008-10-15 · 2010-01-29
Transactions
6
First transaction's obligation
$17,000
Base + all options value (sum of deltas)
$100,078
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V605P7225
NAICS
621399 · OFFICES OF ALL OTHER MISCELLANEOUS HEALTH PRACTITIONERS
Modification chain · 6 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2008-10-15+$17,000= $17,000
- Mod 12008-12-11+$17,000= $34,000
- Mod P000022009-04-08+$25,000= $59,000
- Mod P000032009-09-08+$10,000= $69,000
- Mod P000042009-09-22+$20,000= $89,000
- Mod P000052010-01-29+$11,078= $100,078
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2008-10-15 | +$17,000 | $17,000 | THERAPEUTIC APHEREISIS |
| Mod 1· OTHER ADMINISTRATIVE ACTION | 2008-12-11 | +$17,000 | $34,000 | THERAPEUTIC APHEREISIS |
| Mod P00002· FUNDING ONLY ACTION | 2009-04-08 | +$25,000 | $59,000 | THERAPEUTIC APHEREISIS |
| Mod P00003· FUNDING ONLY ACTION | 2009-09-08 | +$10,000 | $69,000 | THERAPEUTIC APHEREISIS |
| Mod P00004· FUNDING ONLY ACTION | 2009-09-22 | +$20,000 | $89,000 | THERAPEUTIC APHEREISIS |
| Mod P00005· OTHER ADMINISTRATIVE ACTION | 2010-01-29 | +$11,078 | $100,078 | THERAPEUTIC APHEREISIS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI KLXGB46K7SL5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26223C0045 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q508 · HEMATOLOGY & ONCOLOGY | $219,282 | FY2023 |
| 36C26221C0142 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q508 · HEMATOLOGY & ONCOLOGY | $62,240 | FY2021 |
| 36C26221N0664 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $238,752 | FY2021 |
| 36C26220N0976 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $232,397 | FY2020 |
| 36C26220N0927 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $378,225 | FY2020 |
| 36C26220N0912 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $530,588 | FY2020 |
Other recipients under Q301 from 262-NETWORK CONTRACT OFFICE 22 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26216F3459 | QUEST DIAGNOSTICS INCORPORATED | 262-NETWORK CONTRACT OFFICE 22 | $426,000 | FY2016 |
| VA26216F3461 | QUEST DIAGNOSTICS INCORPORATED | 262-NETWORK CONTRACT OFFICE 22 | $240,000 | FY2016 |
| VA26216F3450 | QUEST DIAGNOSTICS INCORPORATED | 262-NETWORK CONTRACT OFFICE 22 | $499,998 | FY2016 |
| VA26216F3458 | QUEST DIAGNOSTICS INCORPORATED | 262-NETWORK CONTRACT OFFICE 22 | $400,000 | FY2016 |
| VA26216F3463 | QUEST DIAGNOSTICS INCORPORATED | 262-NETWORK CONTRACT OFFICE 22 | $499,998 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA605C90103_3600_V605P7225_3600 · retrieved 2026-09-26.